Pharmacogenomics and cardiology: improving treatment with existing drugs
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Pharmacogenomics - 16(2015), 11, Seite 1223 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sorrentino, Matthew J [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: | |
|---|---|
| Themen: |
| doi: |
10.2217/pgs.15.110 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC196094326X |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC196094326X | ||
| 003 | DE-627 | ||
| 005 | 20230513214250.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.2217/pgs.15.110 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC196094326X | ||
| 035 | |a (DE-599)GBVOLC196094326X | ||
| 035 | |a (PRQ)g1571-3cf1de28a00c438f1a2a691fea6d70e91862d321bd3eb296c7e75453f23abfc10 | ||
| 035 | |a (KEY)0406126820150000016001101223pharmacogenomicsandcardiologyimprovingtreatmentwit | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Sorrentino, Matthew J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacogenomics and cardiology: improving treatment with existing drugs |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 650 | 4 | |a Cytochrome P-450 | |
| 650 | 4 | |a Drugs | |
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Pharmacogenetics | |
| 700 | 1 | |a O'Donnell, Peter H |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d London : Future Medicine, 2000 |g 16(2015), 11, Seite 1223 |w (DE-627)320595625 |w (DE-600)2019513-8 |w (DE-576)364344261 |x 1462-2416 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2015 |g number:11 |g pages:1223 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.2217/pgs.15.110 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26369612 |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1712616595 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 16 |j 2015 |e 11 |h 1223 | ||